Welcome to the Life Sciences blog.

Here you will find articles and insights about life sciences and healthcare.

Без категории
July 1, 2020

Celebrating 30 years of BioWorld
Lynn Yoffee
News Director, BioWorld
Clarivate
Без категории
June 19, 2020

2019 trends in regulatory approvals of new medicines
Без категории
May 15, 2020

Applying regulatory flexibility in the age of COVID-19
Dr. Jenny Sharpe
Senior Scientific Writer, Centre for Innovation in Regulatory Science
Clarivate
Без категории
April 7, 2020

The COVID-19 pandemic: European regulators respond
Monia Tumminello
Manager, Cortellis Regulatory Intelligence
Clarivate
Без категории
April 7, 2020

Combating COVID-19: Insights from the BIO Europe conference
Asma Al-Shamahi
Deputy Managing Editor, Cortellis
Clarivate
Без категории
March 31, 2020

Treating a pandemic: Drug repurposing, expanded access and emergency use authorization
Meg Egan-Auderset
Medical & Regulatory Writer, Cortellis
Clarivate
Без категории
March 31, 2020

The trials must go on: Conducting clinical studies during the COVID-19 pandemic
Jaime Polychrones
Medical Writer, Cortellis Regulatory Intelligence
Clarivate
Без категории
March 31, 2020

FDA to expedite public release of guidance documents related to COVID-19
Meg Egan-Auderset
Medical & Regulatory Writer, Cortellis
Clarivate
Без категории
March 31, 2020

FDA unveils emergency investigational COVID-19 convalescent plasma application program
Julie Odland
Medical & Regulatory Writer, Cortellis
Clarivate
Без категории
March 25, 2020

Do EMA and FDA review outcomes for new active substances (NASs) align?
Без категории
March 24, 2020

COVID-19: Scientific innovation will help us beat this virus
Authors:
Shaheen Jaffar - Associate Manager, Content | Robert Poolman - Director, Discovery & Preclinical Products | Rahul Verma - Head of Content Operations
Clarivate
Без категории
March 11, 2020

How can we improve and accelerate patients’ access to medicines in low and middle-income countries?
Jamie Munro
Executive Director - CIRS
Clarivate
Без категории
March 11, 2020

COVID-19 testing: FDA guidance update
Jaime Polychrones
Medical Writer, Cortellis Regulatory Intelligence
Clarivate
Без категории
March 10, 2020

Biopharma M&A activity in Q4 2019 47% higher than in Q4 2018
Elisabet Cruces and Paul D’Souza

Clarivate
Без категории
February 10, 2020

Eleven potential blockbuster drugs offer hope, threaten budgets
Lynn Yoffee
News Director, BioWorld
Clarivate